spironolactone has been researched along with Hyperplasia in 49 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Excerpt | Relevance | Reference |
---|---|---|
" The short-term (9 days) effect of indomethacin in combination with spironolactone was a suppression of hyperreninemia and hyperaldosteronism and an increase in vascular sensitivity to angiotensin II associated with potassium and sodium retention." | 7.66 | Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin. ( Kornerup, HJ; Pedersen, EB; Petersen, VP, 1978) |
"During treatment with indomethacin in a patient with Bartter's syndrome, hypokalemia, high plasma renin concentration, hyperaldosteronism and decreased sensitivity to angiotensin infusion were corrected." | 7.65 | Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. ( Amery, A; Clement, J; Michielsen, P; van Damme B, B; Verberckmoes, R, 1976) |
"In primary aldosteronism the type of adrenal lesion was correctly identified in 28 of 40 patients (70%) by standard adrenal scintigraphy." | 5.26 | Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia. ( Fischer, M; Vetter, H; Vetter, W; Winterg, B; Zidek, W, 1982) |
" Aldosterone itself has been shown to increase cardiovascular fibrosis, therefore, we studied the suppressive effects of eplerenone, a new aldosterone receptor antagonist, on neointimal hyperplasia after coronary stent implantation in swine." | 3.73 | Eplerenone suppresses neointimal formation after coronary stent implantation in swine. ( Iso, Y; Katagiri, T; Sato, T; Suzuki, H; Takeyama, Y; Wakabayashi, K, 2006) |
"When performed with careful regard to confounding factors, measurement of the aldosterone : renin ratio in all hypertensive individuals, followed by fludrocortisone suppression testing to confirm or exclude primary aldosteronism and adrenal venous sampling to determine the subtype, can result in the detection of significant numbers of patients with specifically treatable or potentially curable hypertension." | 3.72 | High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. ( Archibald, C; Cowley, DC; Gordon, RD; Gunasekera, TG; Smithers, BM; Stowasser, M; Ward, G, 2003) |
"The study showed that the main determinants of a surgical cure of hypertension in primary aldosteronism were presence of adenoma and preoperative response to spironolactone." | 3.69 | Factors influencing outcome of surgery for primary aldosteronism. ( Beazley, RM; Celen, O; Melby, JC; O'Brien, MJ, 1996) |
" The short-term (9 days) effect of indomethacin in combination with spironolactone was a suppression of hyperreninemia and hyperaldosteronism and an increase in vascular sensitivity to angiotensin II associated with potassium and sodium retention." | 3.66 | Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin. ( Kornerup, HJ; Pedersen, EB; Petersen, VP, 1978) |
"During treatment with indomethacin in a patient with Bartter's syndrome, hypokalemia, high plasma renin concentration, hyperaldosteronism and decreased sensitivity to angiotensin infusion were corrected." | 3.65 | Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. ( Amery, A; Clement, J; Michielsen, P; van Damme B, B; Verberckmoes, R, 1976) |
"Effects of spironolactone, canrenone and canrenoate-K on adrenal cytochrome P450 (P450) and corticosteroid biosynthesis were examined by studying difference spectra, P450 reduction and corticoid hydroxylation in mitochondrial preparations isolated from zona fasciculata and zona glomerulosa of bovine adrenals and from adrenal adenoma and hyperplastic adrenal cortex removed from patients with hyperaldosteronism." | 3.65 | Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria. ( Cheng, SC; Harding, BW; Sadee, W; Suzuki, K, 1976) |
"Since 1974 primary aldosteronism has been diagnosed in 71 patients in our outpatient clinic." | 1.29 | Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands. ( Erdmenger, L; Grüne, S; Jeck, T; Mengden, T; Vetter, W; Weisser, B, 1994) |
"Spironolactone treatment (100 mg/daily) completely reversed the syndrome of mineralocorticoid excess." | 1.29 | Unilateral adrenal hypersecretion of both aldosterone and cortisol in two first cousins with a syndrome of mineralocorticoid excess but without signs of hypercortisolism. ( Balsano, F; Bonavita, MS; Carlomagno, A; Coassin, S; De Siati, L; Falaschi, P; Ferri, C; Gualdi, G, 1994) |
"Two clinical cases of women with primary hyperaldosteronism are reported." | 1.28 | [2 cases of primary hyperaldosteronism]. ( Dodev, K; Kolarski, V; Nakov, N; Rashkov, R; Vladov, V, 1991) |
"In primary aldosteronism the type of adrenal lesion was correctly identified in 28 of 40 patients (70%) by standard adrenal scintigraphy." | 1.26 | Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia. ( Fischer, M; Vetter, H; Vetter, W; Winterg, B; Zidek, W, 1982) |
"Idiopathic aldosteronism was usually treated by unilateral or subtotal adrenalectomy." | 1.26 | Results of treatment in 68 patients with idiopathic aldosteronism in Japan. ( Kumagai, A, 1980) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (75.51) | 18.7374 |
1990's | 5 (10.20) | 18.2507 |
2000's | 6 (12.24) | 29.6817 |
2010's | 1 (2.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Therwani, S | 1 |
Pedersen, EB | 2 |
Sakurabayashi-Kitade, S | 1 |
Aoka, Y | 1 |
Nagashima, H | 1 |
Kasanuki, H | 1 |
Hagiwara, N | 1 |
Kawana, M | 1 |
Stowasser, M | 1 |
Gordon, RD | 1 |
Gunasekera, TG | 1 |
Cowley, DC | 1 |
Ward, G | 1 |
Archibald, C | 1 |
Smithers, BM | 1 |
Wakabayashi, K | 1 |
Suzuki, H | 2 |
Sato, T | 1 |
Iso, Y | 1 |
Katagiri, T | 1 |
Takeyama, Y | 1 |
Karagiannis, A | 1 |
Tziomalos, K | 1 |
Dona, K | 1 |
Pyrpasopoulou, A | 1 |
Kartali, N | 1 |
Athyros, V | 1 |
Zamboulis, C | 1 |
Miyashita, K | 1 |
Itoh, H | 1 |
Nakao, K | 1 |
Celik, T | 1 |
Iyisoy, A | 1 |
Kursaklioglu, H | 1 |
Isik, E | 1 |
Scoggins, BA | 1 |
Coghlan, JP | 1 |
Menon, M | 1 |
Mersey, JH | 1 |
Fischer, M | 1 |
Vetter, W | 2 |
Winterg, B | 1 |
Zidek, W | 1 |
Vetter, H | 1 |
Aiba, M | 1 |
Kageyama, K | 1 |
Murai, M | 1 |
Tazaki, H | 1 |
Abe, O | 1 |
Saruta, T | 1 |
Ouimet, D | 1 |
Houde, M | 1 |
Kumagai, A | 1 |
Jeck, T | 1 |
Weisser, B | 1 |
Mengden, T | 1 |
Erdmenger, L | 1 |
Grüne, S | 1 |
Ferri, C | 1 |
Falaschi, P | 1 |
Gualdi, G | 1 |
Coassin, S | 1 |
Carlomagno, A | 1 |
De Siati, L | 1 |
Bonavita, MS | 1 |
Balsano, F | 1 |
Celen, O | 1 |
O'Brien, MJ | 1 |
Melby, JC | 1 |
Beazley, RM | 1 |
Kornerup, HJ | 1 |
Petersen, VP | 1 |
Verberckmoes, R | 1 |
van Damme B, B | 1 |
Clement, J | 1 |
Amery, A | 1 |
Michielsen, P | 1 |
Cheng, SC | 1 |
Suzuki, K | 1 |
Sadee, W | 1 |
Harding, BW | 1 |
Kaesemeyer, WH | 1 |
Prisant, LM | 1 |
Carr, AA | 1 |
Nakov, N | 1 |
Vladov, V | 1 |
Kolarski, V | 1 |
Dodev, K | 1 |
Rashkov, R | 1 |
Chen, JH | 1 |
Tsai, JH | 1 |
Lai, YH | 1 |
Hwang, SJ | 1 |
Stimpel, M | 1 |
Dralle, H | 1 |
von zur Mühlen, A | 1 |
Ferriss, JB | 1 |
Brown, JJ | 2 |
Fraser, R | 2 |
Kay, AW | 1 |
Neville, AM | 1 |
O'Muircheartaigh, IG | 1 |
Robertson, JI | 2 |
Symington, T | 1 |
Lever, AF | 2 |
Hänze, S | 1 |
Pierach, CA | 1 |
Stark, G | 1 |
Beilin, LJ | 1 |
Schiffman, N | 1 |
Crane, M | 1 |
Nelson, DH | 1 |
Brackett, NC | 2 |
Koppel, M | 1 |
Randall, RE | 1 |
Nixon, WP | 1 |
Goodman, AD | 1 |
Vagnucci, AH | 1 |
Hartroft, PM | 1 |
Sutherland, LE | 1 |
Hartroft, P | 1 |
Balis, JU | 1 |
Bailey, JD | 1 |
Lynch, MJ | 1 |
Desmit, EM | 1 |
Cost, WS | 1 |
Arant, BS | 1 |
Young, RB | 1 |
Still, WJ | 1 |
Ramanathan, K | 1 |
Gantt, C | 1 |
Grossman, A | 1 |
Modlinger, RS | 1 |
Nicolis, GL | 1 |
Krakoff, LR | 1 |
Gabrilove, JL | 1 |
Ganguly, A | 1 |
Melada, GA | 1 |
Luetscher, JA | 1 |
Dowdy, AJ | 1 |
Horton, R | 1 |
Weinberger, MH | 1 |
Donohue, JP | 1 |
Kaplan, NN | 1 |
Bordás, E | 1 |
Bretter, E | 1 |
Schmidt, P | 1 |
Kopsa, H | 1 |
Kronenberg, KH | 1 |
Meyer, D | 1 |
Zazgornik, J | 1 |
Kotzaurek, R | 1 |
Neumann, E | 1 |
Distler, A | 1 |
Just, HJ | 1 |
Philipp, T | 1 |
Cannon, PJ | 1 |
Leeming, JM | 1 |
Sommers, SC | 1 |
Winters, RW | 1 |
Laragh, JH | 1 |
Gekle, D | 1 |
Wernze, H | 1 |
Langer, KH | 1 |
Fanconi, A | 1 |
Schachenmann, G | 1 |
Nüssli, R | 1 |
Prader, A | 1 |
Fournier, A | 1 |
Nikolaev, OV | 1 |
Gerasimenko, PP | 1 |
Kertsman, VI | 1 |
Kalinin, AP | 1 |
George, JM | 1 |
Wright, L | 1 |
Bell, NH | 1 |
Bartter, FC | 1 |
Gall, G | 1 |
Vaitukaitis, J | 1 |
Haddow, JE | 1 |
Klein, R | 1 |
Birchall, R | 1 |
Batson, HM | 1 |
Ross, EJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Aldosterone-Renin Ratio to Diagnose Primary Aldosteronism in a Population of Patients With Therapy-Resistant Hypertension: Test Characteristics, Diagnostic Value and Predictive Value for Antihypertensive Treatment. The Dutch ARRAT Study.[NCT00407784] | 500 participants | Observational | 2007-01-31 | Recruiting | |||
Characteristics Predicting Clinically Relevant Reduction of Hypertension Following Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis[NCT04761354] | 514 participants (Actual) | Observational | 2016-03-26 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
7 reviews available for spironolactone and Hyperplasia
Article | Year |
---|---|
[Idiopathic hyperaldosteronism (IHA)].
Topics: Adrenal Cortex; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hyperplasia; Miner | 2006 |
Primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Amiloride; Diagnosis, Differential; F | 1980 |
Primary aldosteronism--a review.
Topics: 18-Hydroxycorticosterone; Adenoma; Adolescent; Adrenal Glands; Adult; Aldosterone; Child; Humans; Hy | 1980 |
Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; | 1973 |
Aldosteronism updated.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Dexamethasone; Diagnosis, Differentia | 1973 |
Adrenal causes of hypertension.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adult; Carci | 1974 |
Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): a re-evaluation of the pathophysiology.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aldosterone; Child; Child, Preschool; Female; Humans; Hype | 1968 |
42 other studies available for spironolactone and Hyperplasia
Article | Year |
---|---|
[High doses of aldosterone antagonist is a condition of sufficient blood pressure control in bilateral adrenal hyperplasia].
Topics: Adrenal Glands; Aged; Eplerenone; Humans; Hyperplasia; Hypertension; Male; Mineralocorticoid Recepto | 2015 |
Aldosterone blockade by Spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice.
Topics: Aldosterone; Angiotensin II; Animals; Female; Hyperplasia; Hypertension; Hypertrophy; Male; Mice; Mi | 2009 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
Eplerenone suppresses neointimal formation after coronary stent implantation in swine.
Topics: Actins; Administration, Oral; Animals; Blood Vessel Prosthesis Implantation; Collagen Type I; Collag | 2006 |
Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient.
Topics: Adrenal Glands; Arteriosclerosis; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; | 2005 |
Eplerenone suppresses neointima after coronary stenting in pigs: could it be extrapolated to stent restenosis in humans?
Topics: Angioplasty, Balloon, Coronary; Animals; Collagen; Coronary Restenosis; Disease Models, Animal; Eple | 2007 |
Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia.
Topics: 19-Iodocholesterol; Adenoma; Adosterol; Adrenal Gland Neoplasms; Adult; False Positive Reactions; Fe | 1982 |
Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Animals; Female; Histocytochemistry; Humans; | 1981 |
[Adrenal aldosterone-producing adenoma: a diagnostic approach].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Angiography; Circadian Rhythm; Diagno | 1980 |
Results of treatment in 68 patients with idiopathic aldosteronism in Japan.
Topics: Adolescent; Adrenal Glands; Adrenalectomy; Adult; Child, Preschool; Female; Humans; Hyperaldosteroni | 1980 |
Primary aldosteronism: difference in clinical presentation and long-term follow-up between adenoma and bilateral hyperplasia of the adrenal glands.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Diagnosis, Differential; Follow-Up St | 1994 |
Unilateral adrenal hypersecretion of both aldosterone and cortisol in two first cousins with a syndrome of mineralocorticoid excess but without signs of hypercortisolism.
Topics: Adrenal Glands; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hyperplasia; | 1994 |
Factors influencing outcome of surgery for primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Blood Pressure; Female | 1996 |
Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin.
Topics: Adult; Bartter Syndrome; Diet, Sodium-Restricted; Drug Evaluation; Humans; Hyperaldosteronism; Hyper | 1978 |
Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
Topics: Adult; Bartter Syndrome; Body Weight; Dose-Response Relationship, Drug; Humans; Hyperaldosteronism; | 1976 |
Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11beta- and 18-hydroxylation in bovine and human adrenal cortical mitochondria.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Animals; Canrenoic Ac | 1976 |
Verapamil and nifedipine in combination for the treatment of hypertrophy heart disease.
Topics: Adrenal Gland Diseases; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Humans; | 1991 |
[2 cases of primary hyperaldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Combined Modality Therapy; Female; Humans; Hyperaldosteron | 1991 |
Plasma atrial natriuretic peptide (ANP) in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Atrial Natriuretic Factor; Fem | 1988 |
[Therapy of primary aldosteronism].
Topics: Adenoma; Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Adrenalectomy; Carcinoma; Diagnosis, Dif | 1986 |
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
Topics: Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Age Fac | 1970 |
[Bartter syndrome. Vascular angiotensin II resistance with juxtaglomerular cellular hyperplasia and hyperaldosteronism].
Topics: Adult; Angiotensin II; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Kidney Diseases; Potass | 1965 |
Hypokalaemic alkalosis and hyperplasia of the juxtaglomerular apparatus without hypertension or oedema.
Topics: Adolescent; Alkalosis; Angiotensin II; Blood Pressure; Extracellular Space; Humans; Hyperaldosteroni | 1967 |
Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).
Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Aldosterone; Ammonium Chloride; Angiotensin II; Bicarb | 1968 |
Pathogenesis of Bartter's syndrome.
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Albumins; Aldosterone; Alkalosis; Angiotensin I | 1969 |
Bartter's syndrome. A report of four cases, including three in one sibship, with comparative histologic evaluation of the juxtaglomerular apparatuses and glomeruli.
Topics: Alkalosis; Angiotensin II; Blood Pressure; Carbon Dioxide; Cerebrospinal Fluid Proteins; Electrolyte | 1970 |
An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone.
Topics: Adolescent; Adrenal Cortex Hormones; Albumins; Aldosterone; Alkalosis; Angiotensin II; Creatinine; D | 1970 |
Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease?
Topics: Aldosterone; Alkalosis; Angiotensin II; Bone Diseases; Child; Child, Preschool; Humans; Hyperaldoste | 1970 |
Six year follow-up of a child with Bartter syndrome.
Topics: Aldosterone; Alkalosis; Angiotensin II; Biopsy; Blood Pressure; Child, Preschool; Diet Therapy; Fema | 1973 |
Some observations on the pathogenesis of Bartter's syndrome.
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Blood Volume; Drug Therapy, Combination; Humans; Hype | 1973 |
Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Circadian Rhythm; Dexamethasone; Diet; Female; Hu | 1973 |
[Effect of spironolactone in experimental myocardial necrosis].
Topics: Adrenal Gland Diseases; Adrenal Glands; Animals; Female; Heart Diseases; Hyperplasia; Male; Myocardi | 1972 |
[Bartter's syndrome in adults. Case report with light- and electron-microscopic findings].
Topics: Adult; Alkalosis; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Hypoten | 1973 |
[Research on the pathogenesis of hypertension in primary hyperaldosteronism].
Topics: Adrenal Gland Diseases; Animals; Hemodynamics; Hyperaldosteronism; Hyperplasia; Hypertension; Spiron | 1973 |
[Problems in Bartter's syndrome].
Topics: Alkalosis; Biopsy; Child, Preschool; Female; Glomerular Filtration Rate; Humans; Hyperaldosteronism; | 1971 |
Chronic hypokalaemia with growth retardation, normotensive hyperrenin-hyperaldosteronism ("Bartter's syndrome"), and hypercalciuria. Report of two cases with emphasis on natural history and on catch-up growth during treatment.
Topics: Alkalosis; Calcium; Child; Chronic Disease; Female; Growth Disorders; Humans; Hyperaldosteronism; Hy | 1971 |
[Primary hyperaldosteronism: differentiation between adenoma and primary hyperplasia of the adrenal glands and operative indications].
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Dexamethasone; Diagnosis, Dif | 1971 |
[Primary aldosteronism and its surgical treatment].
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Child; Female; Huma | 1970 |
The syndrome of primary aldosteronism.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood U | 1970 |
Erythrocyte Na flux in a patient with Bartter's syndrome.
Topics: Aldosterone; Alkalosis; Ammonium Chloride; Biological Transport; Biological Transport, Active; Cell | 1971 |
Test for pathologic secretion of aldosterone.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diet; Humans; Hyperaldosteronism; Hyperplasia; Hypert | 1968 |
Conn's syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy.
Topics: Adrenal Gland Diseases; Adrenalectomy; Adult; Alkalosis; Humans; Hydrocortisone; Hyperaldosteronism; | 1965 |